Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene changes in osteopontin are linked to higher risk of atopic dermatitis and asthma.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Severe and early hair loss may indicate a higher risk of heart disease.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

Lowering HER2 levels with certain drugs may reduce metabolic syndrome risk in women.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Wnt-activating drugs generally do not increase cancer risk.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Unhealthy diet and lifestyle choices may increase the risk of hair loss in women.

Alopecia areata may be linked to higher heart disease risk.

Drinking sweetened tea and soda and poor sleep may increase the risk of hair loss in women.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

Older age and specific haircare practices increase the risk of traction alopecia, and education on these factors could help prevent it.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Lifestyle factors like BMI at young adulthood can increase cancer risk in women with Lynch Syndrome, but diet and height don't seem to affect this risk.

Finasteride treats hair loss and reduces prostate cancer risk.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Adults should not consume more than 255 micrograms of selenium per day to avoid risk of hair loss and other side effects.

The document suggests a possible link between FAM111B gene mutations and increased cancer risk, particularly pancreatic cancer.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Early-onset colorectal cancer requires better physician awareness, risk-based screening, and stigma reduction to improve patient experiences.

The impact of virtual care on health and privacy is unclear and may be biased.

Certain drugs can cause male infertility, so fertility counseling and sperm preservation are advised.

Certain blood metabolites are linked to female pattern hair loss, with some increasing risk and others offering protection.

Low-penetration genes might help personalize colorectal cancer prevention.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.